Lobbying Relationship

Client

ALLERGAN, INC.

More records

Lobbying firm

THE MCMANUS GROUP

More records

  • Medicare Parts B and D drugs payments and access.

Duration: to

General Issues: Medicare/Medicaid, Copyright/Patent/Trademark, Health Issues, Financial Institutions/Investments/Securities, Budget/Appropriations, Labor Issues/Antitrust/Workplace, Taxation/Internal Revenue Code

Spending: about $2,950,000 (But it's complicated. Here's why.)

Agencies lobbied since 2008: U.S. Senate, House of Representatives, House of Representatives,, U.S. Senate,

Bills mentioned

H.R.2430: FDA Reauthorization Act of 2017

Sponsor: Greg Walden (R-Ore.)

S.934: FDA Reauthorization Act of 2017

Sponsor: Lamar Alexander (R-Tenn.)

H.R.2376: Drug Diversion and Counterfeit Crackdown Act of 2017

Sponsor: Leonard Lance (R-N.J.)

H.R.5122: To prohibit further action on the proposed rule regarding testing of...

Sponsor: Larry Bucshon (R-Ind.)

H.R.5016: Financial Services and General Government Appropriations Act, 2015

Sponsor: Ander Crenshaw (R-Fla.)

H.R.523: Protect Medical Innovation Act of 2013

Sponsor: Erik Paulsen (R-Minn.)

S.232: Medical Device Access and Innovation Protection Act

Sponsor: Orrin G. Hatch (R-Utah)

H.R.436: Health Care Cost Reduction Act of 2012

Sponsor: Erik Paulsen (R-Minn.)

S.17: Medical Device Access and Innovation Protection Act

Sponsor: Orrin G. Hatch (R-Utah)

S.3187: Food and Drug Administration Safety and Innovation Act

Sponsor: Tom Harkin (D-Iowa)

H.R.452: Medicare Decisions Accountability Act of 2011

Sponsor: Phil Roe (R-Tenn.)

S.668: Health Care Bureaucrats Elimination Act

Sponsor: John Cornyn (R-Texas)

H.R.5209: Healthy Communities through Helping to Offer Incentives and Choices to...

Sponsor: Ron Kind (D-Wis.)

H.R.3590: Patient Protection and Affordable Care Act

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.3962: Preservation of Access to Care for Medicare Beneficiaries and Pension...

Sponsor: John D. Dingell (D-Mich.)

H.R.1548: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

H.R.3200: America's Affordable Health Choices Act of 2009

Sponsor: John D. Dingell (D-Mich.)

H.R.1427: Promoting Innovation and Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.6331: Medicare Improvements for Patients and Providers Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.6049: Energy Improvement and Extension Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

H.R.7060: Renewable Energy and Job Creation Tax Act of 2008

Sponsor: Charles B. Rangel (D-N.Y.)

S.3335: Jobs, Energy, Families, and Disaster Relief Act of 2008

Sponsor: Max Baucus (D-Mont.)

H.R.1424: A bill to provide authority for the Federal Government to purchase and...

Sponsor: Patrick J. Kennedy (D-R.I.)

H.R.2138: Investment in America Act of 2007

Sponsor: Sander M. Levin (D-Mich.)

H.R.1038: Access to Life-Saving Medicine Act

Sponsor: Henry A. Waxman (D-Calif.)

H.R.5629: Pathway for Biosimilars Act

Sponsor: Anna G. Eshoo (D-Calif.)

S.1948: A bill to abrogate the sovereign immunity of Indian tribes as a defense...

Sponsor: Claire McCaskill (D-Mo.)

S.440: PACED Act

Sponsor: Tom Cotton (R-Ark.)

H.R.990: Hatch-Waxman Integrity Act of 2019

Sponsor: Bill Flores (R-Texas)

S.344: Hatch-Waxman Integrity Act of 2019

Sponsor: Thom Tillis (R-N.C.)

S.551: REFUND Act of 2019

Sponsor: Richard J. Durbin (D-Ill.)

S.2543: Prescription Drug Pricing Reduction Act of 2019

Sponsor: Charles E. Grassley (R-Iowa)

H.R.3: Elijah E. Cummings Lower Drug Costs Now Act

Sponsor: Frank Pallone (D-N.J.)

H.R.19: Lower Costs, More Cures Act of 2019

Sponsor: Greg Walden (R-Ore.)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
Nick Shipley Legislative Director, Rep. Jay Inslee
ALANNA TEMME LD, Rep. Jon Porter
John McManus n/a
Barrett Thornhill n/a
Lindsay Bealor n/a
Shawn Bishop n/a
Christina Gervasi n/a
Christina Hochul n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Amendment
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Q2 Report
Q1 Report

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page